Echocardiography in Minnesota

Medistim ASA is a Norwegian medical device manufacturer headquartered in Oslo, with 40 years of innovation in surgical quality assurance. The company is a global leader in transit-time flow measurement (TTFM) and high-frequency ultrasound imaging systems for intraoperative assessment. Medistim manufactures three primary product lines: MiraQ Cardiac (combining ultrasound imaging and TTFM for cardiac surgery), MiraQ Vascular (designed for vascular and transplant surgery), and MiraQ Ultimate (dual-purpose system for both cardiac and vascular procedures). These systems enable surgeons to evaluate graft patency, anastomotic quality, and vessel integrity in real time during cardiac, vascular, and transplant procedures. The company serves hospitals and surgical centers globally through regional distribution partners and direct subsidiaries in the USA, UK, Germany, Norway, Spain, Sweden, Japan, and other countries. Medistim products are supported by clinical evidence from rigorous studies and are backed by comprehensive training, education, and technical support services. The company maintains manufacturing facilities in Horten, Norway, and provides customer service, accounts receivable support, and technical assistance through regional offices. Medistim emphasizes regulatory compliance, clinical rigor, and surgeon education through its EduQ online learning platform and Clinical Application Specialist training programs.

Osypka Medical, headquartered in Berlin, Germany, is a cardiovascular device manufacturer founded in 1986. The company specializes in non-invasive hemodynamic monitoring and temporary cardiac pacing systems. Its core technology platform, Electrical Cardiometry™ (EC™), provides continuous, non-invasive assessment of cardiovascular hemodynamics for critical care, perioperative, and emergency settings. The EC™ product portfolio includes the ICON® and ICONCORE® monitoring systems with disposable EC™ sensors. The company also manufactures temporary cardiac pacemakers under the PACE® brand, including Models 101, 203, and 300, for external pacing therapy and intrinsic rhythm assessment. Complementary product lines include temporary pacing leads (EndoStim®), myocardial electrodes (MyoStim®), and connecting cables (StimConnect®). Osypka offers the CORASIM® heart simulator for clinical training and research. The company maintains a robust educational platform through Osypka Meducate®, providing clinical training in electrical cardiometry and temporary pacing. Products are supported by published clinical evidence, including application in COVID-19 patient management. The company operates a distributor network and provides comprehensive technical support and service. All devices are designed for use in acute care, ICU, operating room, and emergency department environments.

ACIST Medical Systems, a subsidiary of the Bracco Group, manufactures diagnostic and interventional cardiology equipment for catheterization laboratories. The company specializes in contrast delivery systems, intravascular imaging (IVUS), and physiological assessment platforms used in coronary and peripheral interventions. ACIST's core product lines address three clinical domains: angiography (contrast management), imaging (high-definition intravascular ultrasound), and physiology (fractional flow reserve and pressure-derived assessments). The ACIST CVi contrast delivery system has been used in over 30 million clinical cases globally. The ACIST HDi represents the first high-definition IVUS system indicated for both coronary and peripheral vasculature. The ACIST RXi system, paired with Navvus II MicroCatheters, enables physiological assessment of complex coronary artery disease using standard 0.014-inch guidewires. Recently launched is the ACIST dPR algorithm, a non-hyperemic alternative for functional assessment. ACIST also markets the ACIST Pro diagnostic system in Europe. The company serves interventional cardiologists, cardiac surgeons, and interventional radiologists in hospitals and ambulatory cath labs. ACIST maintains manufacturing and service operations in Eden Prairie, Minnesota (global headquarters), with additional offices in Pleasanton, California; Heerlen, Netherlands; and Tokyo, Japan. The company provides clinical education, regulatory compliance support, consumables distribution, and 24/7 technical support. Products are cleared for use in the United States and hold CE marking in Europe.

Visura Technologies, Inc. is a medical device company specializing in visualization technology for minimally invasive cardiology and anesthesia procedures. The company manufactures TEECAD®, the world's first FDA-cleared disposable camera designed to integrate with transesophageal echocardiogram (TEE) probes. TEECAD provides real-time visualization of the esophageal inlet during intubation, enabling physicians to achieve more efficient and effective probe placement during TEE procedures. The device is intended for use in operating rooms, intensive care units, and cardiac catheterization labs where TEE is performed. Visura's technology addresses a clinical gap in procedural visualization, offering a single-use, camera-integrated solution that eliminates cross-contamination concerns and simplifies workflow integration with existing TEE equipment. The company is based in Bloomington, Minnesota, and is led by founder and Chief Medical Officer David Marmor, MD. The board includes experienced healthcare executives and investors, positioning the company for growth in the cardiac imaging and anesthesia equipment markets. As an FDA-cleared medical device manufacturer, Visura demonstrates commitment to regulatory compliance and clinical safety standards required for devices used in critical care settings.

MGC Diagnostics Corporation is a global medical technology company specializing in non-invasive cardiorespiratory diagnostic products and systems. Founded in 1986 and headquartered in Saint Paul, Minnesota, the company designs and manufactures advanced diagnostic equipment for measuring respiratory function, gas exchange, and cardiovascular performance. Key product lines include pulmonary function testing systems, cardiopulmonary exercise testing (CPET/CPX) equipment, FeNO (fractional exhaled nitric oxide) monitoring systems, indirect calorimetry devices, stress testing systems, and treadmills. The company serves hospitals, clinics, sports medicine facilities, and pulmonary rehabilitation centers with integrated solutions for disease detection, chronic disease monitoring, and patient wellness across cardiorespiratory health. MGC Diagnostics provides comprehensive support including technical assistance, training programs, clinical research solutions, and preventive maintenance services.